The use of statins in patients with heart failure: more questions than answers
- PMID: 26623083
- PMCID: PMC4635278
- DOI: 10.3978/j.issn.2072-1439.2015.10.47
The use of statins in patients with heart failure: more questions than answers
Abstract
The use of statins to treat patients with heart failure (HF) is controversial due to conflicting results from large, prospective, randomized, placebo-controlled trials and other smaller studies. A recent comprehensive, well-conducted meta-analysis from Preiss and colleagues sought to determine whether statin therapy had an effect on major HF outcomes such as hospitalization and death. Although the study demonstrated a significant effect of statin therapy on HF hospitalizations, several limitations involving the participant data and nature of statin used in the analyzed trials raise questions about the inferences that can be drawn from the study results.
Keywords: Hydroxymethylglutaryl-CoA reductase inhibitors; heart failure (HF); meta-analysis.
Conflict of interest statement
References
-
- McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005;365:1877-89. - PubMed
-
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S1-45. - PubMed
-
- Lipinski MJ, Abbate A, Fuster V, et al. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms. Nat Clin Pract Cardiovasc Med 2007;4:196-205. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous